Inhibition of ATM enhances the immunogenicity of triple-negative breast cancer by promoting MHC-I expression
Abstract The immunotherapy has achieved some efficacy in triple-negative breast cancer (TNBC), but the benefit population is limited, primarily due to an abnormal immune microenvironment. Thus, it is necessary to explore new molecular targets to enhance the immunogenicity of TNBC cells and improve t...
Saved in:
| Main Authors: | Jiazhen Li, Chenying Liu, Xiaolong Qian, Xiaozi Wang, Hui Sun, Lu Wang, Huiqin Xue, Yuanming Song, Jiamei Liu, Yafang Zhao, Yumian Jia, Fengxia Qin, Tianhua Zhang, Xiaojing Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-08-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07944-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational analysis of the functional impact of MHC-II-expressing triple-negative breast cancer
by: Yang Cui, et al.
Published: (2024-11-01) -
MHC2-SCALE enhances identification of immunogenic neoantigens
by: Joshua G. Gober, et al.
Published: (2025-04-01) -
To what extent does MHC binding translate to immunogenicity in humans?
by: Chloe H. Lee, et al.
Published: (2021-12-01) -
NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors
by: Ying Gao, et al.
Published: (2025-05-01) -
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer
by: Borja Ruiz-Fernández de Córdoba, et al.
Published: (2025-06-01)